Purdue Kicks Off Ch. 11 Confirmation With Plan Overview
By Vince Sullivan · November 12, 2025, 7:28 PM EST
Bankrupt OxyContin maker Purdue Pharma began its Chapter 11 confirmation trial Wednesday with an overview of its latest plan and the myriad settlements that underpin the proposal, including a $6.5 billion...
To view the full article, register now.